Clinical Trial Update: Heparin Dose and Post Operative Bleeding in Cardiopulmonary Bypass Patients

View source ↗

Summary

A completed clinical trial evaluated the relationship between heparin dosing and postoperative bleeding in patients undergoing cardiopulmonary bypass for corona…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Heparin (unfractionated heparin)

Snippet

Sponsor: University of Saskatchewan | Conditions: Coronary Artery Disease | Status: COMPLETED | Results posted: 2014-07-08